TWM
Thrive Wealth Management Portfolio holdings
AUM
$663M
1-Year Est. Return
16.94%
1 Year Est. Return
+16.94%
AUM
$619M
AUM Growth
+$96.1M
(+18%)
Holding
237
Top Buys
| 1 | +$11.6M | |
| 2 | +$8.45M | |
| 3 | +$7.65M | |
| 4 |
Vanguard Value ETF
VTV
|
+$4.13M |
| 5 |
Loar Holdings
LOAR
|
+$3.52M |
Top Sells
| 1 | +$915K | |
| 2 | +$847K | |
| 3 | +$310K | |
| 4 |
Chemed
CHE
|
+$248K |
| 5 |
Amphenol
APH
|
+$218K |
Sector Composition
| 1 | Technology | 7.64% |
| 2 | Financials | 4.17% |
| 3 | Healthcare | 3.03% |
| 4 | Communication Services | 2.44% |
| 5 | Industrials | 2.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Editas Medicine
EDIT
$379M
| $73.7K | 0.01% |
33,500
|
|
||
227
Caribou Biosciences
CRBU
$265M
| $40.3K | 0.01% |
32,000
|
|
||
228
ImmunityBio
IBRX
$2.33B
| $39.7K | 0.01% |
15,041
+4,964
|
|
||
229
OmniAb
OABI
$246M
| $30.1K | ﹤0.01% |
17,281
+1,200
|
|
||
230
Technology Select Sector SPDR Fund
XLK
$94.9B
| – | – |
-1,502
|
|
||
231
Financial Select Sector SPDR Fund
XLF
$54B
| – | – |
-4,151
|
|
||
232
Terns Pharmaceuticals
TERN
$757M
| – | – |
-10,500
|
|
||
233
Rivian
RIVN
$15.5B
| – | – |
-10,965
|
|
||
234
Exelon
EXC
$48.2B
| – | – |
-4,541
|
|
||
235
Elevance Health
ELV
$79.1B
| – | – |
-492
|
|
||
|
236
Chemed
CHE
$6.39B
| – | – |
-403
|
|
||
237
Aflac
AFL
$57.7B
| – | – |
-1,836
|
|